Argus Investors Counsel Inc. lifted its position in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 2.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,065 shares of the medical research company’s stock after purchasing an additional 59 [...]
Argus Investors Counsel Inc. Buys 59 Shares of Thermo Fisher Scientific Inc. $TMO
